National Research (NASDAQ:NRC) Stock Price Passes Above 200 Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC) crossed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $15.68 and traded as high as $21.96. National Research shares last traded at $21.07, with a volume of 38,032 shares traded.

Analyst Upgrades and Downgrades

Separately, Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Monday, January 12th. One analyst has rated the stock with a Hold rating, According to MarketBeat, the company currently has a consensus rating of “Hold”.

National Research Stock Performance

The stock has a market capitalization of $477.45 million, a PE ratio of 30.10 and a beta of 0.47. The business’s 50 day moving average is $18.53 and its 200 day moving average is $15.68. The company has a current ratio of 0.53, a quick ratio of 0.53 and a debt-to-equity ratio of 5.31.

National Research (NASDAQ:NRC) last posted its quarterly earnings data on Monday, October 27th. The company reported $0.23 earnings per share for the quarter. National Research had a net margin of 11.76% and a return on equity of 98.26%. The company had revenue of $34.61 million for the quarter.

Hedge Funds Weigh In On National Research

A number of large investors have recently bought and sold shares of NRC. EverSource Wealth Advisors LLC grew its position in National Research by 9,535.3% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock valued at $28,000 after acquiring an additional 1,621 shares during the last quarter. Russell Investments Group Ltd. boosted its stake in shares of National Research by 85.6% during the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock valued at $26,000 after purchasing an additional 921 shares during the period. Raymond James Financial Inc. bought a new position in shares of National Research in the second quarter worth about $34,000. PNC Financial Services Group Inc. grew its holdings in shares of National Research by 1,072.5% in the second quarter. PNC Financial Services Group Inc. now owns 2,087 shares of the company’s stock worth $35,000 after purchasing an additional 1,909 shares during the last quarter. Finally, BNP Paribas Financial Markets increased its stake in National Research by 85.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after buying an additional 1,150 shares during the period. Hedge funds and other institutional investors own 47.26% of the company’s stock.

About National Research

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.